Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome

Miyakis S, Lockshin MD, Atsumi T, et al: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 4:295–306. 2006. View Article : Google Scholar : PubMed/NCBI

Meroni PL, Borghi MO, Raschi E and Tedesco F: Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 7:330–339. 2011. View Article : Google Scholar : PubMed/NCBI

Soltesz P, Der H, Veres K, et al: Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction. Rheumatology (Oxford). 47:1628–1634. 2008. View Article : Google Scholar : PubMed/NCBI

Silveira LH, Hubble CL, Jara LJ, et al: Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. Am J Med. 93:403–411. 1992. View Article : Google Scholar : PubMed/NCBI

Cowchock FS, Reece EA, Balaban D, Branch DW and Plouffe L: Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 166:1318–1323. 1992. View Article : Google Scholar

Ghazeeri GS and Kutteh WH: Immunological testing and treatment in reproduction: frequency assessment of practice patterns at assisted reproduction clinics in the USA and Australia. Hum Reprod. 16:2130–2135. 2001. View Article : Google Scholar : PubMed/NCBI

Pierangeli SS, Espinola R, Liu X, Harris EN and Salmon JE: Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype. Arthritis Rheum. 44:876–883. 2001. View Article : Google Scholar

Branch DW, Peaceman AM, Druzin M, et al: A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol. 182:122–127. 2000. View Article : Google Scholar

Sebire NJ, Fox H, Backos M, Rai R, Paterson C and Regan L: Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod. 17:1067–1071. 2002. View Article : Google Scholar

Alalaf S: Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome. Arch Gynecol Obstet. 285:641–647. 2012. View Article : Google Scholar : PubMed/NCBI

Stephenson MD, Ballem PJ, Tsang P, et al: Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin. J Obstet Gynaecol Can. 26:729–734. 2004.

Salmon JE and Girardi G: Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation. Trans Am Clin Climatol Assoc. 118:99–114. 2007.PubMed/NCBI

Hochart H, Jenkins PV, Smith OP and White B: Low-molecular weight and unfractionated heparins induce a downregulation of inflammation: decreased levels of proinflammatory cytokines and nuclear factor-kappaB in LPS-stimulated human monocytes. Br J Haematol. 133:62–67. 2006. View Article : Google Scholar

Wang L, Brown JR, Varki A and Esko JD: Heparin’s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest. 110:127–136. 2002.

Guerin J, Sheng Y, Reddel S, Iverson GM, Chapman MG and Krilis SA: Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome. J Biol Chem. 277:2644–2649. 2002. View Article : Google Scholar